Trials / Completed
CompletedNCT03726853
The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497
A Phase 2, Randomized, Double-blind, Multi-center, Parallel-group Trial to Evaluate the Efficacy and Safety of CKD-497
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of CKD-497
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-497 200mg | CKD-497 200mg |
| DRUG | CKD-497 300mg | CKD-497 300mg |
| DRUG | CKD-497 placebo | Placebo of CKD-497 |
| DRUG | Comparator | Comparator |
| DRUG | Comparator placebo | Comparator placebo |
Timeline
- Start date
- 2018-05-29
- Primary completion
- 2019-03-21
- Completion
- 2019-03-21
- First posted
- 2018-11-01
- Last updated
- 2020-02-06
Locations
15 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03726853. Inclusion in this directory is not an endorsement.